Pēdējā atjaunošana :
19/11/2024
Antibiotika   Penicillin G sodium  
Injekcija
Šķīduma stabilitāte Maisījuma stabilitāte Stabilitāti ietekmējoši faktori Saderība Levadīšanas veids Literatūras saraksts pdf
   Ķīmiskā uzbūve   

Oriģinālais nosaukums   Oriģinālais nosaukums     

Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām

Benapen Brazīlija
Bencilpenicilina Čīle, Ekvadora, Peru
Benpen Austrālija, Jaunzēlande
Bensylpenicillin Zviedrija
Benzapen Irāna
Benzatec Dienvidāfrikas Republika
Benzatron Brazīlija
Benzylpenicillin Dānija, Ēģipte, Norvēģija, Somija, Zviedrija
Benzylpenicilline Tunisija
Biconcillina Ekvadora
Crystapen Īrija, Kanāda, Lielbritānija
Declin Meksika
Fortepen Saūda Arābija
Geepenil Somija
Natrium penicillin G Holande
Novopen Dienvidāfrikas Republika
Pebencil Venecuēla
Penbendox Meksika
Penibiot Spānija
Penicillin Norvēģija
Penicillina G sodica Argentīna, Čīle, Ekvadora, Kolumbija, Portugāle
Penilevel Spānija
Sodiopen Spānija
Unicillina Spānija
Literatūras saraksts   Injekcija   Literatūras saraksts : Penicillin G sodium  
tips publicēšana
13 Žurnāls Stiles ML, Allen LV.
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440 Žurnāls Stiles ML, Tu YH, Allen LV.
Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057 Žurnāls Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072 Žurnāls Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241 Žurnāls Rayani S, Jamali F.
The stability of penicillin G sodium in 5% dextrose in water minibags after freezing.
Can J Hosp Pharm 1985 ; 38: 162-163.
1263 Žurnāls Allwood MC, Brown PW.
The effect of buffering on the stability of reconstituted benzylpenicillin injection.
Int J Pharm Pract 1992 ; 1: 242-244.
1725 Žurnāls Oliver C, Law S.
Compatibility of oxytocin, zidovudine, and penicillin G.
Can J Hosp Pharm 2001 ; 54: 112-113.
2056 Žurnāls Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.
Stability of benzylpenicillin during continuous home intravenous therapy.
J Antimicrob Chemother 2004 ; 53: 675-677.
2087 Žurnāls Ferreira E, Forest JM, Hildgen P.
Compatibility of dimenhydrinate injectable by Y administration.
Pharmactuel 2004 ; 37: 17-20.
2090 Žurnāls Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
3012 Žurnāls Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3227 Žurnāls Simon B, Hancu G, Gy?resi A.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520 Laboratorija Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 Laboratorija Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3540 Laboratorija Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3580 Laboratorija Cytarabine Accord - Résumé des caractéristiques du produit
Accord Healthcare France 2016
3585 Laboratorija Benzylpenicillin sodium - Summary of Product Characteristics
Genus Pharmaceuticals 2008
3643 Laboratorija Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3648 Žurnāls Hossain M.A, Friciu M, Aubin S, Leclair G.
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.
Am J Health-Syst Pharm 2014 ; 71:669-673.
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3702 Žurnāls McDougall D.A.J, McWhinney.
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931 Laboratorija Trimébutine (Débridat®) - Résumé des caractéristiques du produit
Pfizer Laboratoire 2016
3964 Žurnāls Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
4154 Laboratorija Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4319 Žurnāls Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4389 Žurnāls Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4590 Žurnāls Smith E.K, McWhinney MPhil B.C.
Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service.
J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603 Žurnāls Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4831 Žurnāls Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I.
Frequently acquired drugs in neonatal intensive care and their physical compatibility.
Acta Paediatr 2022 ;111:2307–2314. 
4837 Žurnāls De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.

  Mentions Légales